- Outpatient cervical brachytherapy in the setting of ongoing antiplatelet therapy or oral anticoagulation
-
Valakh V, Munns SA, Trombetta
- KMID: 2409943
- J Gynecol Oncol.
- 2018 May;29(3):e42.
- doi: 10.3802/jgo.2018.29.e42
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Gynecologic cancer in Brazil and the law of sixty days
-
Paulino E, de Melo AC, Nogueira-Rodrigues A, Thuler LC
- KMID: 2409944
- J Gynecol Oncol.
- 2018 May;29(3):e44.
- doi: 10.3802/jgo.2018.29.e44
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical and health policy experiences with HPV prevalence within the Hungarian organized cervical cancer screening program
-
Vajda R, Juhász K, Endrei D
- KMID: 2409945
- J Gynecol Oncol.
- 2018 May;29(3):e45.
- doi: 10.3802/jgo.2018.29.e45
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Screening for Lynch syndrome using risk assessment criteria in patients with ovarian cancer
-
Takeda T, Tsuji K, Banno K, Yanokura M, Kobayashi , Tominaga E, Aoki D
- KMID: 2409933
- J Gynecol Oncol.
- 2018 May;29(3):e29.
- doi: 10.3802/jgo.2018.29.e29
OBJECTIVE: Lynch syndrome is a cancer predisposition syndrome caused by germline mutation of DNA mismatch repair (MMR) genes. Lynch syndrome only causes about 0.4% of cases of ovarian cancer, which... -
- CITED
-
- Close
- SHARE
-
- Close
- A score system for complete cytoreduction in selected recurrent ovarian cancer patients undergoing secondary cytoreductive surgery: predictors- and nomogram-based analyses
-
Bogani G, Tagliabue , Signorelli M, Ditto A, Martinelli F, Chiappa V, Mosca L, Sabatucci , Leone Roberti Maggiore U, Lorusso D, Raspagliesi F
- KMID: 2409941
- J Gynecol Oncol.
- 2018 May;29(3):e40.
- doi: 10.3802/jgo.2018.29.e40
OBJECTIVE: To test the applicability of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) and Memorial Sloan Kettering (MSK) criteria in predicting complete cytoreduction (CC) in patients undergoing secondary cytoreductive surgery (SCS) for... -
- CITED
-
- Close
- SHARE
-
- Close
- Oncologic effectiveness of nerve-sparing radical hysterectomy in cervical cancer
-
Ditto A, Bogani G, Leone Roberti Maggiore U, Martinelli F, Chiappa V, Lopez C, Perotto S, Lorusso D, Raspagliesi F
- KMID: 2409942
- J Gynecol Oncol.
- 2018 May;29(3):e41.
- doi: 10.3802/jgo.2018.29.e41
OBJECTIVE: Nerve-sparing radical hysterectomy (NSRH) was introduced with the aim to reduce pelvic dysfunctions related to conventional radical hysterectomy (RH). Here, we sought to assess the effectiveness and safety of... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on relapse pattern in primary epithelial ovarian cancer: a propensity score based case-control study
-
Ceresoli M, Verrengia , Montori G, Busci L, Coccolini , Ansaloni L, Frigerio L
- KMID: 2409946
- J Gynecol Oncol.
- 2018 May;29(3):e53.
- doi: 10.3802/jgo.2018.29.e53
OBJECTIVE: Hyperthermic intraperitoneal chemotherapy (HIPEC) has been proposed as a treatment in ovarian cancer. A recently published RCT demonstrated that HIPEC prolongs disease-free survival (DFS) and overall survival (OS) in... -
- CITED
-
- Close
- SHARE
-
- Close
- What MRI features suspect malignant pure mesenchymal uterine tumors rather than uterine leiomyoma with cystic degeneration?
-
Kim TH, Kim JW, Kim SY, Kim SH, Cho JY
- KMID: 2409930
- J Gynecol Oncol.
- 2018 May;29(3):e26.
- doi: 10.3802/jgo.2018.29.e26
OBJECTIVE: To retrospectively assess conventional magnetic resonance imaging (MRI) features that differentiate malignant pure mesenchymal uterine tumors (MPMUT); endometrial stromal sarcoma (ESS) and leiomyosarcoma (LMS) from uterine leiomyoma with cystic... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic factors for patients with early-stage uterine serous carcinoma without adjuvant therapy
-
Tate K, Yoshida H, Ishikawa M, Uehara T, Ikeda SI, Hiraoka N, Kato T
- KMID: 2409935
- J Gynecol Oncol.
- 2018 May;29(3):e34.
- doi: 10.3802/jgo.2018.29.e34
OBJECTIVE: Uterine serous carcinoma (USC) is an aggressive type 2 endometrial cancer. Data on prognostic factors for patients with early-stage USC without adjuvant therapy are limited. This study aims to... -
- CITED
-
- Close
- SHARE
-
- Close
- Endometrial cancer risk and survival by tumor MMR status
-
Nagle CM, O'Mara TA, Tan Y, Buchanan D, Obermair A, Blomfield , Quinn MA, Webb PM, Spurdle AB, on behalf of the Australian Endometrial Cancer Study Group
- KMID: 2409940
- J Gynecol Oncol.
- 2018 May;29(3):e39.
- doi: 10.3802/jgo.2018.29.e39
OBJECTIVE: The risk of developing endometrial cancer (EC) and/or survival following a diagnosis of EC might differ by tumor DNA mismatch repair (MMR) status. We assessed the association between tumor... -
- CITED
-
- Close
- SHARE
-
- Close
- Insulin resistance and overweight prolonged fertility-sparing treatment duration in endometrial atypical hyperplasia patients
-
Yang B, Xie L, Zhang H, Zhu Q, Du Y, Luo X, Chen X
- KMID: 2409936
- J Gynecol Oncol.
- 2018 May;29(3):e35.
- doi: 10.3802/jgo.2018.29.e35
OBJECTIVE: Our previous study showed that insulin resistance (IR) was related to endometrial hyperplasia as well as endometrial cancer. But the exact impact of IR on fertility-sparing treatment in endometrial... -
- CITED
-
- Close
- SHARE
-
- Close
- Androgen receptor as a prognostic biomarker and therapeutic target in uterine leiomyosarcoma
-
Baek MH, Park JY, Park Y, Kim KR, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH
- KMID: 2409934
- J Gynecol Oncol.
- 2018 May;29(3):e30.
- doi: 10.3802/jgo.2018.29.e30
OBJECTIVE: To investigate the expression of androgen receptor (AR) and its correlation with disease status and survival outcome in uterine leiomyosarcoma with other hormone receptors. METHODS: The medical records and paraffin... -
- CITED
-
- Close
- SHARE
-
- Close
- Retrospective analysis of sites of recurrence in stage I epithelial ovarian cancer
-
Hirose S, Tanabe H, Nagayoshi , Hirata Y, Narui C, Ochiai K, Isonishi S, Takano H, Okamoto A
- KMID: 2409938
- J Gynecol Oncol.
- 2018 May;29(3):e37.
- doi: 10.3802/jgo.2018.29.e37
OBJECTIVE: The aim of the study is to investigate recurrence of stage I epithelial ovarian cancer. METHODS: Six hundred two patients diagnosed with stage I epithelial ovarian cancer at 4 hospitals... -
- CITED
-
- Close
- SHARE
-
- Close
- Programmed death-1 (PD-1) expression in cervical intraepithelial neoplasia and its relationship with recurrence after conization
-
Chang H, Hong JH, Lee JK, Cho HW, Ouh YT, Min KJ, So KA
- KMID: 2409931
- J Gynecol Oncol.
- 2018 May;29(3):e27.
- doi: 10.3802/jgo.2018.29.e27
OBJECTIVE: Impaired local cellular immunity contributes to persistent human papillomavirus (HPV) infection and development of cervical intraepithelial neoplasia (CIN). Programmed death-1 (PD-1) and its ligands PD-ligand-1 (L1) and PD-L2 are... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk factors in progression from endometriosis to ovarian cancer: a cohort study based on medical insurance data
-
Chiang AJ, Chang C, Huang CH, Huang WC, Kan YY, Chen J
- KMID: 2409932
- J Gynecol Oncol.
- 2018 May;29(3):e28.
- doi: 10.3802/jgo.2018.29.e28
OBJECTIVE: The objective was to identify risk factors that were associated with the progression from endometriosis to ovarian cancer based on medical insurance data. METHODS: The study was performed on a... -
- CITED
-
- Close
- SHARE
-
- Close
- E2/E6 ratio and L1 immunoreactivity as biomarkers to determine HPV16-positive high-grade squamous intraepithelial lesions (CIN2 and 3) and cervical squamous cell carcinoma
-
Choi YJ, Lee A, Kim TJ, Jin HT, Seo YB, Park JS, Lee SJ
- KMID: 2409939
- J Gynecol Oncol.
- 2018 May;29(3):e38.
- doi: 10.3802/jgo.2018.29.e38
OBJECTIVE: Human papillomavirus (HPV) 16 is the most carcinogenic HPV genotype. We investigated if HPV16 L1 capsid protein and E2/E6 ratio, evaluated by cervical cytology, may be used as biomarkers... -
- CITED
-
- Close
- SHARE
-
- Close
- Diagnostic value of integrated ¹â¸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients
-
Lee YJ, Kim YM, Jung PS, Lee JJ, Kim JK, Kim YT, Nam JH
- KMID: 2409937
- J Gynecol Oncol.
- 2018 May;29(3):e36.
- doi: 10.3802/jgo.2018.29.e36
OBJECTIVE: The aim of this study was to evaluate the diagnostic value of integrated 18F-fluoro-2-deoxyglucose-positron emission tomography/computed tomography (18F-FDG-PET/CT) for suspected recurrence of epithelial ovarian cancer (EOC) with non-disseminated lesions. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
